Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-043779
Filing Date
2025-05-15
Accepted
2025-05-15 10:07:28
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241202-10q_60degrees.htm   iXBRL 10-Q 746638
2 CERTIFICATION ea0241202ex31-1_60degrees.htm EX-31.1 9761
3 CERTIFICATION ea0241202ex31-2_60degrees.htm EX-31.2 9692
4 CERTIFICATION ea0241202ex32-1_60degrees.htm EX-32.1 3881
5 CERTIFICATION ea0241202ex32-2_60degrees.htm EX-32.2 4065
  Complete submission text file 0001213900-25-043779.txt   5511532

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sxtp-20250331.xsd EX-101.SCH 54014
7 XBRL CALCULATION FILE sxtp-20250331_cal.xml EX-101.CAL 48113
8 XBRL DEFINITION FILE sxtp-20250331_def.xml EX-101.DEF 267362
9 XBRL LABEL FILE sxtp-20250331_lab.xml EX-101.LAB 513080
10 XBRL PRESENTATION FILE sxtp-20250331_pre.xml EX-101.PRE 277558
71 EXTRACTED XBRL INSTANCE DOCUMENT ea0241202-10q_60degrees_htm.xml XML 531214
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41719 | Film No.: 25949578
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)